Page last updated: 2024-09-04

tariquidar and Hypoxia

tariquidar has been researched along with Hypoxia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azab, AK; Azab, F; de la Puente, P; Federico, C; Fiala, M; Kusdono, HD; Muz, B; Salama, NN; Vij, R1

Other Studies

1 other study(ies) available for tariquidar and Hypoxia

ArticleYear
Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:12

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Bortezomib; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Multiple Myeloma; Oligopeptides; Proteasome Inhibitors; Quinolines

2017